recently completed the Drug Safety: Pharmacovigilance course and found it to be extremely insightful and well-structured. The course provides a comprehensive overview of both pre- and post-marketing drug safety monitoring, covering topics such as adverse event reporting, regulatory frameworks, active vs. passive surveillance, and signal detection.
The content is presented clearly, with real-world case studies like Rofecoxib and Infliximab, which help bridge theory and practice. I especially appreciated the sections on data mining techniques, FDA regulatory requirements, and international pharmacovigilance systems like VigiBase and Sentinel.
The course materials and assessments reinforce learning effectively, and the 6-month access period allowed me to revisit complex topics at my own pace. Overall, this course is highly recommended for healthcare professionals, clinical researchers, and anyone interested in drug safety.